Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00365521
NCT00365521
Unknown
Not Applicable

Prophylactic Photodynamic Therapy to Organ Transplant Patients

Bispebjerg Hospital1 site in 1 country50 target enrollmentStarted: April 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOrgan Transplants

Overview

Phase
Not Applicable
Enrollment
50
Locations
1
OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

To evaluate a possible prophylactic efficacy of photodynamic therapy on the incidence of non-melanoma skin cancer, actinic keratoses, warts and keratoses in recently organ transplanted recipients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Masking
Single

Eligibility Criteria

Ages
40 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Organ transplant recipients.
  • •Age 40 years or older.

Exclusion Criteria

  • •Patients younger than 40 years and older than 70 years.
  • •Clinical signs of skin cancer, actinic keratoses or warts at the time of inclusion.
  • •Previous photodynamic therapy to the skin areas investigated.
  • •Pregnancy or breast feeding patients.
  • •Patients with porphyria.
  • •Patients with a tendency to produce hypertrophic scars or keloids.
  • •Patients with known allergy to Metvix.
  • •Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients etc.).

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Prophylactic photodynamic therapy for organ transplant patients.
EUCTR2008-006863-35-SEBispebjerg Hospital50
Completed
Not Applicable
Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant RecipientsNonmelanoma Skin Cancers
NCT02751151Inova Health Care Services10
Not yet recruiting
Phase 4
Effects of Photodynamic Therapy as aid on non-surgical treatment of Aggressive PeriodontitisAggressive Periodontitis
RBR-4gq6khrniversidade Federal do Rio Grande do Norte
Completed
Phase 4
Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing CreamLentigo Maligna
NCT02685592Joint Authority for Päijät-Häme Social and Health Care10
Completed
Not Applicable
Photodynamic Therapy in Patients With GingivitisGingivitisOrthodontic Appliance ComplicationPhotodynamic Therapy
NCT04037709University of Nove de Julho20